Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Supramolecular nanofiber vaccines
Immersive Virtual Environment Testing Area
A Data Resource for Analyzing Blood and Marrow Transplants
Williams Syndrome: International Scientific and Professional Conference
A Peptide Nanoparticle Nicotine Vaccine
Recently added grants:
Awarding of travel grants to early-career clinician scientists to attend the Association for Research in Vision and Ophthalmology annual meeting (2018-2022).
Injury Response Mediated Pathogenesis in Renal Ciliopathies
Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
Mechanisms of vitamin A deprivation and replacement therapy
Determination of Cone Photoreceptor Fate
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005126-001
Application #
6994811
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2005
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Ge
Lynch, Patrick M. / University of Texas MD Anderson Cancer Center
$3,251,125
Publications
Lynch, Patrick M; Ayers, Gregory D; Hawk, Ernie et al.
(2010)
The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Am J Gastroenterol 105:1437-43
Comments
Be the first to comment on this grant